Advisory Committee on the Medical Uses of Isotopes; Meeting Notice, 5465 [2018-02375]

Download as PDF Federal Register / Vol. 83, No. 26 / Wednesday, February 7, 2018 / Notices financial responsibility for health care benefits. 8. National Indian Gaming Commission, Division of Public Affairs (DAA–0600–2017–0012, 9 items, 2 temporary items). Non-senior level biographical files and speeches. Proposed for permanent retention are bulletins, press releases, senior official biographical files and speeches, and digital audiUS ovisual records documenting agency programs and activities. 9. Postal Regulatory Commission, Agency-wide (DAA–0458–2018–0001, 37 items, 11 temporary items). Staff records related to internal briefings, draft reports, and protective conditions. Proposed for permanent retention are records related to dockets, required reporting, high level officials, and Commission meetings and hearings. 10. United States International Trade Commission, Office of the General Counsel (DAA–0081–2017–0004, 11 items, 10 temporary items). Administrative or operational related legal memoranda, litigation case files, investigations and summaries of violations to Commission rules, trade policy support files, policy development and review files, and working files. Proposed for permanent retention are historically significant legal memoranda. Laurence Brewer, Chief Records Officer for the U.S. Government. [FR Doc. 2018–02404 Filed 2–6–18; 8:45 am] BILLING CODE 7515–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes; Meeting Notice Nuclear Regulatory Commission. ACTION: Notice of meeting. sradovich on DSK3GMQ082PROD with NOTICES AGENCY: The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 7– 8, 2018. A sample of agenda items to be discussed during the public session includes: (1) A discussion on medicalrelated events; (2) an update on the worldwide supply and domestic production of molybdenum-99; (3) a discussion on the resources needed to address the development of emerging medical technologies; and (4) a discussion of staff’s evaluation of the ACMUI’s recommendations related to medical event reporting under title 10 VerDate Sep<11>2014 18:17 Feb 06, 2018 Jkt 244001 Code of Federal Regulations (10 CFR) 35.3045 and impact on safety culture at medical institutions. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doccollections/acmui/meetings/2018.html or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: March 7, 2018, from 8:30 a.m. to 2:30 p.m. and March 8, 2018, from 8:30 a.m. to 2:45 p.m. Eastern Standard Time. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Holiday using the information below. The meeting will also be webcast live at https:// video.nrc.gov/. Contact Information: Sophie Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415–7865. Conduct of the Meeting Philip O. Alderson, M.D. will chair the meeting. Dr. Alderson will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday using the contact information listed above. All submittals must be received by March 2, 2018, three business days before the meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2018.html on or about April 19, 2018. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Holiday of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 5465 Dated at Rockville, Maryland this 1st day of February, 2018. For the Nuclear Regulatory Commission. Russell E. Chazell, Advisory Committee Management Officer. [FR Doc. 2018–02375 Filed 2–6–18; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 52–025 and 52–026; NRC– 2008–0252] Southern Nuclear Operating Company, Inc., Vogtle Electric Generating Station, Units 3 and 4; Addition of a Residual Heat Removal Suction Relief Valve for Low-Temperature Overpressure Protection Nuclear Regulatory Commission. ACTION: Exemption and combined license amendment; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is granting an exemption to allow a departure from the certification information of Tier 1 of the generic design control document (DCD) and is issuing License Amendment Nos. 104 and 103 to Combined Licenses (COL), NPF–91 and NPF–92, respectively. The COLs were issued to Southern Nuclear Operating Company, Inc., and Georgia Power Company, Oglethorpe Power Corporation, MEAG Power SPVM, LLC, MEAG Power SPVJ, LLC, MEAG Power SPVP, LLC, and the City of Dalton, Georgia (the licensee); for construction and operation of the Vogtle Electric Generating Plant (VEGP) Units 3 and 4, located in Burke County, Georgia. The granting of the exemption allows the changes to Tier 1 information that is requested in the amendment. Because the acceptability of the exemption was determined in part by the acceptability of the amendment, the exemption and amendment are being issued concurrently. SUMMARY: The exemptions and amendments were issued on December 20, 2017. ADDRESSES: Please refer to Docket ID NRC–2008–0252 when contacting the NRC about the availability of information regarding this document. You may access information related to this document, which the NRC possesses and is publicly available, using any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2008–0252. Address questions about NRC dockets to Carol DATES: E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 83, Number 26 (Wednesday, February 7, 2018)]
[Notices]
[Page 5465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02375]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The U.S. Nuclear Regulatory Commission will convene a meeting of 
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 
7-8, 2018. A sample of agenda items to be discussed during the public 
session includes: (1) A discussion on medical-related events; (2) an 
update on the worldwide supply and domestic production of molybdenum-
99; (3) a discussion on the resources needed to address the development 
of emerging medical technologies; and (4) a discussion of staff's 
evaluation of the ACMUI's recommendations related to medical event 
reporting under title 10 Code of Federal Regulations (10 CFR) 35.3045 
and impact on safety culture at medical institutions. The agenda is 
subject to change. The current agenda and any updates will be available 
at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html or by emailing Ms. Sophie Holiday at the contact information 
below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: March 7, 2018, from 8:30 a.m. to 
2:30 p.m. and March 8, 2018, from 8:30 a.m. to 2:45 p.m. Eastern 
Standard Time.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live at https://video.nrc.gov/.
    Contact Information: Sophie Holiday, email: [email protected], 
telephone: (301) 415-7865.

Conduct of the Meeting

    Philip O. Alderson, M.D. will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday using the contact information listed 
above. All submittals must be received by March 2, 2018, three business 
days before the meeting, and must pertain to the topics on the agenda 
for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about April 19, 2018.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland this 1st day of February, 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2018-02375 Filed 2-6-18; 8:45 am]
 BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.